Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Schizophrenia (8)
- Depression (2)
- Early intervention (2)
- Antipsychotic drugs (1)
- Atypical antipsychotic (1)
-
- Cognitive enhancement (1)
- Comorbidity (1)
- Duration of untreated psychosis (1)
- Early psychosis (1)
- Mental disorder (1)
- Mental health (1)
- Mood symptoms (1)
- Outcome (1)
- Paliperidone (1)
- Pharmacological Management (1)
- Psychosis (1)
- Relapse (1)
- Risk assessment (1)
- Schizoaffective disorder (1)
- Serum prolactinlevels (1)
- Suicide (1)
- Suicide behaviour (1)
- UHR research (1)
- Ultra high risk research (1)
Articles 1 - 12 of 12
Full-Text Articles in Entire DC Network
Beyond Early Intervention, Amresh Srivastava
Beyond Early Intervention, Amresh Srivastava
Psychiatry Presentations
No abstract provided.
Current Understanding And Pharmacological Management Of Suicide Behavior In Clinical Setting, Amresh Shrivastava
Current Understanding And Pharmacological Management Of Suicide Behavior In Clinical Setting, Amresh Shrivastava
Psychiatry Presentations
This presentation addresses these issues:
• Nature of problem in clinical settings
• Current understanding about suicide behavior (neurobiology)
• What can be done to deal with suicide in clinical settings
• Pharmacological management
Should Schizoaffective Disorder Be Dropped From Dsm V, Amresh Srivastava
Should Schizoaffective Disorder Be Dropped From Dsm V, Amresh Srivastava
Psychiatry Presentations
No abstract provided.
Switching And Selecting Atypical Antipsychotic Drugs: Paliperidone, Amresh Srivastava
Switching And Selecting Atypical Antipsychotic Drugs: Paliperidone, Amresh Srivastava
Psychiatry Presentations
No abstract provided.
Baseline Serum Prolactinin Drug Naïve First Episode Schizophrenia Predicts A Positive Clinical And Social Outcome At Five Years, Post Discharge Follow-Up, Amresh Srivastava, Manoj Tamhane, Meghana Thakar, Yves Bureau, Nilesh Shah
Baseline Serum Prolactinin Drug Naïve First Episode Schizophrenia Predicts A Positive Clinical And Social Outcome At Five Years, Post Discharge Follow-Up, Amresh Srivastava, Manoj Tamhane, Meghana Thakar, Yves Bureau, Nilesh Shah
Psychiatry Presentations
Serum prolactinis an indicator of tuberoinfundibulardopamine activity. It is reported to increase in wide variety of mental illnesses. It has close relationship with antipsychotic therapy. However, its relationship with psychopathology and outcome is not clear. Serum prolactinlevel was measured in 30 male and 30 female drug naive patients of schizophrenia. Subsequently, these patients were treated with antipsychotics. The severity of psychopathology at the baseline and subsequent improvement at the end of 3 weeks and 6 weeks was assessed on modified brief psychiatric rating scale (mBPRS). Available to follow up at five years 18 males & 22 females patients were reassessed …
Coping Up Challenges Of Risk Assessment: Towards A New Scale: Sis-Map, Amresh Srivastava, Charles Nelson
Coping Up Challenges Of Risk Assessment: Towards A New Scale: Sis-Map, Amresh Srivastava, Charles Nelson
Psychiatry Presentations
No abstract provided.
Identifying Schizophrenia: Paradigm Shift ‘The Uhr Research’, Amresh Srivastava
Identifying Schizophrenia: Paradigm Shift ‘The Uhr Research’, Amresh Srivastava
Psychiatry Presentations
No abstract provided.
First Episode Is The Best Episode: Lessons And Limitations In Duration Of Untreated Psychosis (Dup) And Outcome In Schizophrenia, Amresh Srivastava, Larry Stitt, Meghana Thakar, Gurusamy Chinnasamy, Nilesh Shah
First Episode Is The Best Episode: Lessons And Limitations In Duration Of Untreated Psychosis (Dup) And Outcome In Schizophrenia, Amresh Srivastava, Larry Stitt, Meghana Thakar, Gurusamy Chinnasamy, Nilesh Shah
Psychiatry Presentations
Background: Early intervention in psychosis is an opportunity. Research ahs shown that if any thing community members can do to prevent psychosis is to report early. This has opened newer vistas for understanding the complexity of brain and behaviour in schizophrenia. At the same time it has raised the bar of expectations regarding its correlation to outcome. It finally narrows down to meaningful public campaign for awareness, which will decide success of research to clinics in schizophrenia management. Duration of untreated psychosis (DUP) has emerged as a reliable predictor of outcome and provides credence to development of early intervention services. …
Mood Symptoms As Comorbidity In Schizophrenia, Amresh Srivastava
Mood Symptoms As Comorbidity In Schizophrenia, Amresh Srivastava
Psychiatry Presentations
No abstract provided.
Relapse Prevention In Schizophrenia, Amresh Srivastava
Relapse Prevention In Schizophrenia, Amresh Srivastava
Psychiatry Presentations
No abstract provided.
Early Psychosis: A Bridge To Future, Amresh Srivastava
Early Psychosis: A Bridge To Future, Amresh Srivastava
Psychiatry Presentations
No abstract provided.
Atypical Antipsychotics And Cognitive Enhancement In Schizophrenia: The Current Status, Amresh Srivastava
Atypical Antipsychotics And Cognitive Enhancement In Schizophrenia: The Current Status, Amresh Srivastava
Psychiatry Presentations
No abstract provided.